HYDROCORTISONE\NEOMYCIN\POLYMYXIN B: 334 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
334
Total FAERS Reports
1 (0.3%)
Deaths Reported
9
Hospitalizations
334
As Primary/Secondary Suspect
3
Life-Threatening
12
Disabilities
Active Ingredient: HYDROCORTISONE\NEOMYCIN SULFATE\POLYMYXIN B SULFATE ·
First Report: 20080616 · Latest Report: 20250821
What Are the Most Common HYDROCORTISONE\NEOMYCIN\POLYMYXIN B Side Effects?
#1 Most Reported
Ear discomfort
58 reports (17.4%)
#2 Most Reported
Ear pain
33 reports (9.9%)
#3 Most Reported
Eye irritation
32 reports (9.6%)
All HYDROCORTISONE\NEOMYCIN\POLYMYXIN B Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Ear discomfort | 58 | 17.4% | 0 | 0 |
| Ear pain | 33 | 9.9% | 0 | 0 |
| Eye irritation | 32 | 9.6% | 0 | 0 |
| Accidental exposure to product | 30 | 9.0% | 0 | 0 |
| Hypoacusis | 29 | 8.7% | 0 | 0 |
| Deafness | 23 | 6.9% | 0 | 0 |
| Wrong product administered | 23 | 6.9% | 0 | 0 |
| Drug ineffective | 22 | 6.6% | 0 | 0 |
| Tinnitus | 21 | 6.3% | 0 | 0 |
| Eye pain | 20 | 6.0% | 0 | 0 |
| Incorrect route of product administration | 19 | 5.7% | 0 | 0 |
| Pruritus | 19 | 5.7% | 0 | 0 |
| Expired product administered | 16 | 4.8% | 0 | 0 |
| Ear infection | 15 | 4.5% | 0 | 0 |
| Instillation site pain | 15 | 4.5% | 0 | 0 |
| Ocular hyperaemia | 15 | 4.5% | 0 | 0 |
| Incorrect route of drug administration | 14 | 4.2% | 0 | 0 |
| Headache | 13 | 3.9% | 0 | 2 |
| Dizziness | 12 | 3.6% | 0 | 0 |
| Erythema | 12 | 3.6% | 0 | 0 |
Who Reports HYDROCORTISONE\NEOMYCIN\POLYMYXIN B Side Effects? Age & Gender Data
Gender: 66.5% female, 33.5% male. Average age: 57.1 years. Most reports from: US. View detailed demographics →
Is HYDROCORTISONE\NEOMYCIN\POLYMYXIN B Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 2 | 0 | 0 |
| 2013 | 5 | 0 | 3 |
| 2014 | 15 | 0 | 0 |
| 2015 | 11 | 0 | 0 |
| 2016 | 16 | 0 | 0 |
| 2017 | 17 | 1 | 1 |
| 2018 | 15 | 0 | 0 |
| 2019 | 22 | 0 | 0 |
| 2020 | 19 | 0 | 0 |
| 2021 | 11 | 0 | 0 |
| 2022 | 16 | 0 | 0 |
| 2023 | 15 | 0 | 0 |
| 2024 | 15 | 0 | 1 |
| 2025 | 11 | 0 | 1 |
What Is HYDROCORTISONE\NEOMYCIN\POLYMYXIN B Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 118 |
| Ear infection | 89 |
| Ear pain | 12 |
| Ear disorder | 10 |
| Eye infection | 9 |
| Otitis externa | 9 |
| Otitis media | 6 |
| Product use in unapproved indication | 6 |
| Excessive cerumen production | 5 |
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs Alternatives: Which Is Safer?
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROCORTISONE\PRAMOXINE
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROGEN PEROXIDE
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROMORPHONE
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROQUINONE
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROXOCOBALAMIN
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROXYCHLOROQUINE
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROXYCHLOROQUINE DIPHOSPHATE
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROXYETHYL STARCH 130/0.4
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROXYPROGESTERONE
HYDROCORTISONE\NEOMYCIN\POLYMYXIN B vs HYDROXYPROGESTERONE CAPROATE
Official FDA Label for HYDROCORTISONE\NEOMYCIN\POLYMYXIN B
Official prescribing information from the FDA-approved drug label.